Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China
Recruiting now
Conditions studied: Cancer, Cancer-related Problem/Condition
In brief
The goal of this observational study is to learn about the impact of chemotherapy-related toxicity on older cancer patients in China. The main question it aims to answer is: Does the Cancer and Aging Research Group (CARG) chemotherapy toxicity risk score predict chemotherapy-related toxicity in Chinese cancer patients over age 70? Participants over age 70 on systemic chemotherapy will answer questions listed in the CARG chemotherapy toxicity risk tool.
Key facts
- Study ID
- NCT06717178
- Run by
- RenJi Hospital
- People needed
- 322
- Starts
- 2024-12-24
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2025-04-02
Who can join
Age: 70 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age≥ 70 years old
- Confirmed diagnosis of solid tumor (any stage)
- ECOG-PS score 0-2 points
- Admission to the hospital for a new chemotherapy regimen (initial or change)
- Patients need to have the ability to read and write, or communicate in Chinese
- The patient must have the ability to give informed consent.
You may not qualify if…
- Patients who are on immunotherapy and/or targeted therapy only
- Patients with hematologic malignancy
- Patients with severe infections (sepsis, severe respiratory tract infections, severe urinary tract infections, severe abdominal infections, etc.).
- Patients with severe heart, liver, and kidney dysfunction or failure
Where it is running
- Henan Cancer Hospital — Zhengzhou, Henan, China (enrolling)
- Renji Hospital — Shanghai, Shanghai Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.